Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up

R. G. Langley; M. Lebwohl; G. G. Krueger; P. O. Szapary; Y. Wasfi; D. Chan; M. C. Hsu; Y. You; Y. Poulin; N. Korman; J. C. Prinz; K. Reich

doi:10.1111/bjd.13469

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up

R. G. Langley, M. Lebwohl, G. G. Krueger, P. O. Szapary, Y. Wasfi, D. Chan, M. C. Hsu, Y. You, Y. Poulin, N. Korman, J. C. Prinz, K. Reich

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

163 引用（Scopus）

源语言	英语
页（从-至）	1371-1383
页数	13
期刊	British Journal of Dermatology
卷	172
期	5
DOI	https://doi.org/10.1111/bjd.13469
出版状态	已出版 - 5月 1 2015

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1111/bjd.13469

其它文件与链接

引用此

Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P. O., Wasfi, Y., Chan, D., Hsu, M. C., You, Y., Poulin, Y., Korman, N., Prinz, J. C., & Reich, K. (2015). Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up. British Journal of Dermatology, 172(5), 1371-1383. https://doi.org/10.1111/bjd.13469

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up. / Langley, R. G.; Lebwohl, M.; Krueger, G. G. 等.
在: British Journal of Dermatology, 卷 172, 号码 5, 01.05.2015, 页码 1371-1383.

科研成果: 期刊稿件 › 文章 › 同行评审

Langley, RG, Lebwohl, M, Krueger, GG, Szapary, PO, Wasfi, Y, Chan, D, Hsu, MC, You, Y, Poulin, Y, Korman, N, Prinz, JC & Reich, K 2015, 'Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up', British Journal of Dermatology, 卷 172, 号码 5, 页码 1371-1383. https://doi.org/10.1111/bjd.13469

@article{2b1b304a1e7c43dbb7587aa14b4f6951,

title = "Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up",

author = "Langley, {R. G.} and M. Lebwohl and Krueger, {G. G.} and Szapary, {P. O.} and Y. Wasfi and D. Chan and Hsu, {M. C.} and Y. You and Y. Poulin and N. Korman and Prinz, {J. C.} and K. Reich",

note = "Publisher Copyright: {\textcopyright} 2014 British Association of Dermatologists.",

year = "2015",

month = may,

day = "1",

doi = "10.1111/bjd.13469",

language = "English",

volume = "172",

pages = "1371--1383",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis

T2 - Results from the PHOENIX 2 study through 5 years of follow-up

AU - Langley, R. G.

AU - Lebwohl, M.

AU - Krueger, G. G.

AU - Szapary, P. O.

AU - Wasfi, Y.

AU - Chan, D.

AU - Hsu, M. C.

AU - You, Y.

AU - Poulin, Y.

AU - Korman, N.

AU - Prinz, J. C.

AU - Reich, K.

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84929092448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929092448&partnerID=8YFLogxK

U2 - 10.1111/bjd.13469

DO - 10.1111/bjd.13469

M3 - Article

C2 - 25307931

AN - SCOPUS:84929092448

SN - 0007-0963

VL - 172

SP - 1371

EP - 1383

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: Results from the PHOENIX 2 study through 5 years of follow-up

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此